Alzheimer's disease & dementia

Modulating the brain's immune system may curb damage in Alzheimer's

New research suggests that calming the brain's immune cells might prevent or lessen the damaging inflammation seen in Alzheimer's disease. The study points to the key role of the hormone and neurotransmitter norepinephrine, ...

Medications

EU approves sale of new Alzheimer's drug, with conditions

The European Commission said Wednesday that it had given formal approval for Leqembi, a long-awaited new treatment for early-stage Alzheimer's disease, to be sold in the EU under strict conditions.

page 1 from 2